Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1998 | 12-1997 | 12-1996 | 12-1995 | 12-1994 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 341,620 | 496,720 | N/A | 4,864,820 | N/A |
| Marketable Securities | 273,630 | 698,360 | N/A | 0 | N/A |
| Receivables | 2,520,730 | 2,293,440 | N/A | 5,119,200 | N/A |
| Inventories | 1,323,380 | 1,193,440 | N/A | 2,725,500 | N/A |
| Other current assets | 10 | 0 | 0 | 0 | 0 |
| TOTAL | $4,459,370 | $4,681,960 | $N/A | $12,709,520 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 3,633,490 | 3,198,360 | N/A | 8,983,880 | N/A |
| Investments And Advances | 242,120 | 200,000 | 0 | 0 | 0 |
| Other Non-Current Assets | 636,810 | 132,780 | 0 | 630,420 | 0 |
| TOTAL | $4,512,420 | $3,531,140 | $N/A | $9,614,300 | $N/A |
| Total Assets | $8,971,800 | $8,213,110 | $8,490,000 | $22,323,820 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 29,850 | 27,860 | N/A | 7,173,200 | N/A |
| Other current liabilities | 3,043,110 | 2,747,540 | N/A | 0 | N/A |
| TOTAL | $3,321,720 | $3,054,090 | $N/A | $7,173,200 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 747,920 | 836,060 | N/A | 1,448,860 | N/A |
| aiOther Non-Current Liabilities | 718,060 | 762,280 | 0 | 1,628,980 | 0 |
| TOTAL | $1,480,900 | $1,618,010 | $N/A | $3,077,840 | $N/A |
| Total Liabilities | $4,802,650 | $4,672,130 | $N/A | $10,251,040 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 394,690 | 388,520 | N/A | 0 | N/A |
| Retained earnings | 3,066,330 | 2,429,500 | N/A | 0 | N/A |
| Other shareholders' equity | 655,070 | 683,620 | 0 | 12,072,780 | 0 |
| TOTAL | $4,169,150 | $3,540,980 | $N/A | $12,072,780 | $N/A |
| Total Liabilities And Equity | $8,971,800 | $8,213,110 | $0 | $22,323,820 | $0 |